Dr. Daniel Wallerstorfer, CEO and founder of Novogenia, a vibrant Austrian genetics company, discusses founding his own company and the innovative services Novogenia provides to ensure genetics are a staple part of global preventative measures. He also provides an insight into the future of genetic analysis and the positive overall effects genetic testing can have on the entire healthcare system. What was the overriding motivation to found your own company?
"There are around 30 companies doing genetic testing in Europe and thankfully we supply 75 percent of the market. In fact, Novogenia is one of the few to have its own lab."